Successful targeting of ErbB2 receptors—is PTEN the key?
- 31 August 2004
- journal article
- editorial
- Published by Elsevier in Cancer Cell
- Vol. 6 (2), 103-104
- https://doi.org/10.1016/j.ccr.2004.08.001
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004
- PTEN: One Gene, Many SyndromesHuman Mutation, 2003
- Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitorsOncogene, 2003
- Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabNature, 2003
- Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targetsNature Medicine, 2000